MENU
+Compare
BEIGF
Stock ticker: OTC
AS OF
Nov 10 closing price
Price
$25.29
Change
+$0.37 (+1.48%)
Capitalization
43.93B

BEIGF BeOne Medicines Ltd. Forecast, Technical & Fundamental Analysis

Founded in 2010 in Beijing and having listed on the Hong Kong exchange in 2018, BeOne is a commercial-stage biotechnology company with global sales... Show more

BEIGF
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for BEIGF with price predictions
Nov 12, 2025

BEIGF's Stochastic Oscillator is sitting in overbought zone for 2 days

Expect a price pull-back in the near future.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis
Bullish Trend Analysis

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. BEIGF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (8.811) is normal, around the industry mean (24.439). BEIGF has a moderately high P/E Ratio (632.365) as compared to the industry average of (63.753). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.001). Dividend Yield (0.000) settles around the average of (0.046) among similar stocks. P/S Ratio (7.358) is also within normal values, averaging (322.723).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BEIGF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
BEIGF
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
c/o Mourant Governance Services (Cayman) Limited
Phone
+1 345 949-4123
Employees
10600
Web
https://www.beigene.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OTLK1.470.19
+14.84%
Outlook Therapeutics
VHI12.94-0.15
-1.15%
Valhi
NN12.25-0.34
-2.70%
NextNav
LUMN8.12-0.43
-5.03%
Lumen Technologies
BTSGU109.10-5.80
-5.05%
BrightSpring Health Services

BEIGF and Stocks

Correlation & Price change

A.I.dvisor tells us that BEIGF and GOVX have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BEIGF and GOVX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BEIGF
1D Price
Change %
BEIGF100%
N/A
GOVX - BEIGF
29%
Poorly correlated
+0.38%
CING - BEIGF
29%
Poorly correlated
+3.54%
POLBF - BEIGF
25%
Poorly correlated
N/A
XLO - BEIGF
9%
Poorly correlated
-2.66%
CGTX - BEIGF
9%
Poorly correlated
-1.71%
More